Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

Breye Therapeutics has announced that danegaptide, a potential oral treatment for nonproliferative diabetic retinopathy, has ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 diabetes—mostly due to a lack of early screening, poor blood sugar control, and delayed ...

Survival models using electronic health record data show promise in predicting progression to proliferative diabetic ...

India, often labelled the diabetic capital of the world, faces an alarming crisis with over 77 million people diagnosed with ...

A diabetic eye screening appointment usually takes about 30 minutes: We’ll ask you to read some letters on a chart. We’ll put drops in your eyes. These may sting for a few seconds and may make your ...

A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

An AI model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient.

The trial subjects were adults with either type 1 or type 2 diabetes, exhibiting central involvement in diabetic macular ...